1. Arslan E, Atilgan H & Yavasoglu I 2009. The prevalence of Helicobacter pylori in obese subjects. European journal of internal medicine. 20 (7): 695-697.
2. Ashwell M, Gunn P & Gibson S 2012. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity. 13 (3): 275-286.
3. Boylan MR, Khalili H, Huang ES & Chan AT 2014. Measures of adiposity are associated with increased risk of peptic ulcer. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 12 (10): 1688-1694.
4. Browning LM, Hsieh SD & Ashwell M 2010. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutrition research reviews. 23 (2): 247-269.
5. Chen LW, et al. 2015a. Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study. PloS one. 10 (5): e0128671.
6. Chen TP, et al. 2015b. Helicobacter Pylori Infection is Positively Associated with Metabolic Syndrome in Taiwanese Adults: a Cross-Sectional Study. Helicobacter. 20 (3): 184-191.
7. Eusebi LH, Zagari RM & Bazzoli F 2014. Epidemiology of Helicobacter pylori infection. Helicobacter. 19 Suppl 1: 1-5.
8. Felley C, et al. 2012. Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia. World journal of gastroenterology. 18 (17): 2076-2083.
9. Hussain SA & Hamid S 2014. Helicobacter pylori in humans: Where are we now? Advanced biomedical research. 3: 63.
10. Lender N, et al. 2014. Review article: Associations between Helicobacter pylori and obesity--an ecological study. Alimentary pharmacology & therapeutics. 40 (1): 24-31.
11. Mancia G, et al. 2013. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of hypertension. 31 (7): 1281-1357.
12. Naja F, et al. 2012. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter. 17 (6): 444-451.
13. Rahmani A, et al. 2015. Investigation of the Prevalence of Obesity in Iran: a Systematic Review and Meta-Analysis Study. Acta medica Iranica. 53 (10): 596-607.
14. Sayehmiri F, et al. 2014. A Systematic Review and Meta-Analysis Study to Investigate the Prevalence of Helicobacter pylori and the Sensitivity of its Diagnostic Methods in Iran. Iranian Red Crescent medical journal. 16 (6): e12581.
15. Sepanlou SG, et al. 2015. Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran. Archives of Iranian medicine. 18 (3): 144-152.
16. Shrivastava SR, Shrivastava PS & Ramasamy J 2014. The determinants and scope of public health interventions to tackle the global problem of hypertension. International journal of preventive medicine. 5 (7): 807-812.
17. Sotuneh N, Hosseini SR, Shokri-Shirvani J, Bijani A & Ghadimi R 2014. Helicobacter pylori infection and metabolic parameters: is there an association in elderly population? International journal of preventive medicine. 5 (12): 1537-1542.
18. Tan HJ & Goh KL 2012. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. Journal of digestive diseases. 13 (7): 342-349.
19. Vahdat K, et al. 2013. Association of pathogen burden and hypertension: the Persian Gulf Healthy Heart Study. American journal of hypertension. 26 (9): 1140-1147.
20. Vijayvergiya R & Vadivelu R 2015. Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World journal of cardiology. 7 (3): 134-143.
21. Vo HD, et al. 2015. Inverse correlation between Helicobacter pylori colonization and obesity in a cohort of inner city children. Helicobacter. 20 (1): 64-68.
22. Wang Y, et al. 2014. Homocysteine as a risk factor for hypertension: a 2-year follow-up study. PloS one. 9 (10): e108223.
23. Whalen MB & Massidda O 2015. Helicobacter pylori: enemy, commensal or, sometimes, friend? Journal of infection in developing countries. 9 (6): 674-678.
24. WHO 2011. World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. .
25. Wong F, Rayner-Hartley E & Byrne MF 2014. Extraintestinal manifestations of Helicobacter pylori: a concise review. World journal of gastroenterology. 20 (34): 11950-11961.
26. Xu C, et al. 2014. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter. 19 (6): 437-442.
27. Zhang Y, et al. 2015. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. Journal of infection in developing countries. 9 (9): 945-953.